admin
AstraZeneca Pharma stock has risen 57 percent in the last one year, outperforming benchmark Nifty 50 which has risen 30 percent during the same period.
Michael Burry’s next ‘Big Short’: An inside look at his analysis showing AI is a bubble
Top Wall Street analysts favor these 3 stocks for solid upside potential
Activist Ananym Capital sees upside if Baker Hughes spins off its oilfield services business
Does Berkshire’s big tech bet signal a new risk tolerance in Omaha?
Robinhood shares head for brutal weekly loss as bitcoin, AI stocks are hit hard
Muddy Waters Capital’s Carson Block makes rare long call in Canadian miner Snowline Gold
Joe Terranova on the quantitative approach to the JOET ETF that identifies winners like Palantir early
Alphabet rallies after Berkshire reveals stake. Why Buffett’s firm likely bought it
Top Wall Street analysts are bullish on these 3 dividend stocks
Jana Partners push to break up Cooper Cos. could change the stock’s outlook